Wellfully Ltd
ASX:WFL
Wellfully Ltd
Cash from Financing Activities
Wellfully Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Wellfully Ltd
ASX:WFL
|
Cash from Financing Activities
AU$580.9k
|
CAGR 3-Years
-48%
|
CAGR 5-Years
42%
|
CAGR 10-Years
-13%
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Financing Activities
-AU$431.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Financing Activities
AU$3.6m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-18%
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash from Financing Activities
AU$36.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
46%
|
|
Probiotec Ltd
ASX:PBP
|
Cash from Financing Activities
-AU$11.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Financing Activities
AU$231.6k
|
CAGR 3-Years
-70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Wellfully Ltd's Cash from Financing Activities?
Cash from Financing Activities
580.9k
AUD
Based on the financial report for Dec 31, 2023, Wellfully Ltd's Cash from Financing Activities amounts to 580.9k AUD.
What is Wellfully Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-13%
Over the last year, the Cash from Financing Activities growth was -83%. The average annual Cash from Financing Activities growth rates for Wellfully Ltd have been -48% over the past three years , 42% over the past five years , and -13% over the past ten years .